Sabra Health Care REIT, Inc. ( NASDAQ: SBRA) Q4 2024 Earnings Conference Call February 20, 2025 1:00 PM ET Lukas Hartwich - EVP, Finance Rick Matros - CEO, President & Chair Talya Nevo-Hacohen - CIO, Treasurer & EVP Mike Costa - CFO

Truist Financial analyst Michael Lewis maintained a Hold rating on Sabra Healthcare REIT (SBRA – Research Report) today. The company’s shares

Sabra Healthcare (SBRA) reported $182.35 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 11.6%. EPS of $0.36 for the same period compares to $0.07 a year ago.

Q4 2024 Management View CEO Rick Matros highlighted that Sabra delivered consistent strong performance in Q4 2024, with senior housing and skilled nursing portfolios showing improvement. SHOP same-store occupancy increased by 80 basis points sequentially,

The health care real estate investment trust, based in Tustin, California, posted revenue of $182.3 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $183.2 million. Sabra expects full-year funds from operations in the range of $1.48 to $1.51 per share.